Gal S - Search Results

1

Novel multifunctional anti-Alzheimer drugs with various CNS neurotransmitter targets and neuroprotective moieties.

Van der Schyf CJ, Mandel S, Geldenhuys WJ, Amit T, Avramovich Y, Zheng H, Fridkin M, Gal S, Weinreb O, Bar Am O, Sagi Y, Youdim MB. Van der Schyf CJ, et al. Among authors: gal s. Curr Alzheimer Res. 2007 Dec;4(5):522-36. doi: 10.2174/156720507783018226. Curr Alzheimer Res. 2007. PMID: 18220515 Review.

2

Multifunctional neuroprotective drugs targeting monoamine oxidase inhibition, iron chelation, adenosine receptors, and cholinergic and glutamatergic action for neurodegenerative diseases.

Van der Schyf CJ, Gal S, Geldenhuys WJ, Youdim MB. Van der Schyf CJ, et al. Among authors: gal s. Expert Opin Investig Drugs. 2006 Aug;15(8):873-86. doi: 10.1517/13543784.15.8.873. Expert Opin Investig Drugs. 2006. PMID: 16859391 Review.

3

Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition.

Zheng H, Gal S, Weiner LM, Bar-Am O, Warshawsky A, Fridkin M, Youdim MB. Zheng H, et al. Among authors: gal s. J Neurochem. 2005 Oct;95(1):68-78. doi: 10.1111/j.1471-4159.2005.03340.x. J Neurochem. 2005. PMID: 16181413 Free article.

4

M30, a novel multifunctional neuroprotective drug with potent iron chelating and brain selective monoamine oxidase-ab inhibitory activity for Parkinson's disease.

Gal S, Fridkin M, Amit T, Zheng H, Youdim MB. Gal S, et al. J Neural Transm Suppl. 2006;(70):447-56. doi: 10.1007/978-3-211-45295-0_68. J Neural Transm Suppl. 2006. PMID: 17017567

5

Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion.

Gal S, Zheng H, Fridkin M, Youdim MB. Gal S, et al. J Neurochem. 2005 Oct;95(1):79-88. doi: 10.1111/j.1471-4159.2005.03341.x. J Neurochem. 2005. PMID: 16181414 Free article.

6

Restoration of nigrostriatal dopamine neurons in post-MPTP treatment by the novel multifunctional brain-permeable iron chelator-monoamine oxidase inhibitor drug, M30.

Gal S, Zheng H, Fridkin M, Youdim MB. Gal S, et al. Neurotox Res. 2010 Jan;17(1):15-27. doi: 10.1007/s12640-009-9070-9. Epub 2009 Jul 16. Neurotox Res. 2010. PMID: 19609632

7

limited potentiation of blood pressure in response to oral tyramine by the anti-Parkinson brain selective multifunctional monoamine oxidase-AB inhibitor, M30.

Gal S, Abassi ZA, Youdim MB. Gal S, et al. Neurotox Res. 2010 Aug;18(2):143-50. doi: 10.1007/s12640-009-9128-8. Epub 2009 Nov 6. Neurotox Res. 2010. PMID: 19894083

8

Hydrodynamics based transfection in normal and fibrotic rats.

Yeikilis R, Gal S, Kopeiko N, Paizi M, Pines M, Braet F, Spira G. Yeikilis R, et al. Among authors: gal s. World J Gastroenterol. 2006 Oct 14;12(38):6149-55. doi: 10.3748/wjg.v12.i38.6149. World J Gastroenterol. 2006. PMID: 17036386 Free PMC article.

9

Pneumocystis pneumonia in Cushing's syndrome.

Nevez G, Le Gal S. Nevez G, et al. Among authors: le gal s. Ann Endocrinol (Paris). 2024 May 1:S0003-4266(24)00053-2. doi: 10.1016/j.ando.2023.08.006. Online ahead of print. Ann Endocrinol (Paris). 2024. PMID: 38724339 No abstract available.

10

The epidemiology of fungal infections in transplant patients.

Mahmoud DE, Herivaux A, Morio F, Briard B, Vigneau C, Desoubeaux G, Bouchara JP, Gangneux JP, Nevez G, Gal SL, Papon N. Mahmoud DE, et al. Among authors: gal sl. Biomed J. 2024 Apr 3:100719. doi: 10.1016/j.bj.2024.100719. Online ahead of print. Biomed J. 2024. PMID: 38580051 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

251 results

Search Page